We found that Sirt1 protein to be significantly upregulated in DLBCL tumor tissues, including Non-GCB DLBCL tumor tissues, while it was only marginally detected in normal lymph node tissues (compared with the negative-staining cases) (Figure 1A, 1B). The gene discussed is SIRT1; the disease is diffuse large B-cell lymphoma.